Literature DB >> 27344280

Failure to Rescue Rates After Coronary Artery Bypass Grafting: An Analysis From The Society of Thoracic Surgeons Adult Cardiac Surgery Database.

Fred H Edwards1, Victor A Ferraris2, Paul A Kurlansky3, Kevin W Lobdell4, Xia He5, Sean M O'Brien5, Anthony P Furnary6, J Scott Rankin7, Christina M Vassileva8, Frank L Fazzalari9, Mitchell J Magee10, Vinay Badhwar11, Ying Xian5, Jeffrey P Jacobs12, Moritz C Wyler von Ballmoos13, David M Shahian14.   

Abstract

BACKGROUND: Failure to rescue (FTR) is increasingly recognized as an important quality indicator in surgery. The Society of Thoracic Surgeons National Database was used to develop FTR metrics and a predictive FTR model for coronary artery bypass grafting (CABG).
METHODS: The study included 604,154 patients undergoing isolated CABG at 1,105 centers from January 2010 to January 2014. FTR was defined as death after four complications: stroke, renal failure, reoperation, and prolonged ventilation. FTR was determined for each complication and a composite of the four complications. A statistical model to predict FTR was developed.
RESULTS: FTR rates were 22.3% for renal failure, 16.4% for stroke, 12.4% for reoperation, 12.1% for prolonged ventilation, and 10.5% for the composite. Mortality increased with multiple complications and with specific combinations of complications. The multivariate risk model for prediction of FTR demonstrated a C index of 0.792 and was well calibrated, with a 1.0% average difference between observed/expected (O/E) FTR rates. With centers grouped into mortality terciles, complication rates increased modestly (11.4% to 15.7%), but FTR rates more than doubled (6.8% to 13.9%) from the lowest to highest terciles. Centers in the lowest complication rate tercile had an FTR O/E of 1.14, whereas centers in the highest complication rate tercile had an FTR O/E of 0.91.
CONCLUSIONS: CABG mortality rates vary directly with FTR, but complication rates have little relation to death. FTR rates derived from The Society of Thoracic Surgeons data can serve as national benchmarks. Predicted FTR rates may facilitate patient counseling, and FTR O/E ratios have promise as valuable quality metrics.
Copyright © 2016 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27344280     DOI: 10.1016/j.athoracsur.2016.04.051

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

1.  Failure to rescue: A candidate quality metric for durable left ventricular assist device implantation.

Authors:  Michael J Pienta; Thomas M Cascino; Donald S Likosky; Amir A Ghaferi; Keith D Aaronson; Francis D Pagani; Michael P Thompson
Journal:  J Thorac Cardiovasc Surg       Date:  2021-11-09       Impact factor: 6.439

2.  Preoperative serum ST2 level predicts acute kidney injury after adult cardiac surgery.

Authors:  Kevin W Lobdell; Devin M Parker; Donald S Likosky; Michael Rezaee; Moritz Wyler von Ballmoos; Shama S Alam; Sherry Owens; Heather Thiessen-Philbrook; Todd MacKenzie; Jeremiah R Brown
Journal:  J Thorac Cardiovasc Surg       Date:  2018-04-11       Impact factor: 5.209

3.  Travel distance and regional access to cardiac valve surgery.

Authors:  Robert B Hawkins; Matthew Byler; Clifford Fonner; Irving L Kron; Leora T Yarboro; Alan M Speir; Mohammed A Quader; Gorav Ailawadi; J Hunter Mehaffey
Journal:  J Card Surg       Date:  2019-08-02       Impact factor: 1.620

4.  Intraoperative Fluid Balance and Perioperative Outcomes After Aortic Valve Surgery.

Authors:  Bradford B Smith; William J Mauermann; Suraj M Yalamuri; Ryan D Frank; Carmelina Gurrieri; Arman Arghami; Mark M Smith
Journal:  Ann Thorac Surg       Date:  2020-03-07       Impact factor: 4.330

5.  Impact of hospital safety-net status on failure to rescue after major cardiac surgery.

Authors:  Yas Sanaiha; Sarah Rudasill; Sohail Sareh; Alexandra Mardock; Habib Khoury; Boback Ziaeian; Richard Shemin; Peyman Benharash
Journal:  Surgery       Date:  2019-07-12       Impact factor: 3.982

6.  Importance of high-performing teams in the cardiovascular intensive care unit.

Authors:  Lauren R Kennedy-Metz; Atilio Barbeito; Roger D Dias; Marco A Zenati
Journal:  J Thorac Cardiovasc Surg       Date:  2021-03-31       Impact factor: 5.209

7.  Interhospital failure to rescue after coronary artery bypass grafting.

Authors:  Donald S Likosky; Raymond J Strobel; Xiaoting Wu; Robert S Kramer; Baron L Hamman; James K Brevig; Michael P Thompson; Amir A Ghaferi; Min Zhang; Eric J Lehr
Journal:  J Thorac Cardiovasc Surg       Date:  2021-01-29       Impact factor: 6.439

8.  Determinants of Value in Coronary Artery Bypass Grafting.

Authors:  Alexander A Brescia; Joceline V Vu; Chang He; Jun Li; Steven D Harrington; Michael P Thompson; Edward C Norton; Scott E Regenbogen; John D Syrjamaki; Richard L Prager; Donald S Likosky
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2020-11-12

Review 9.  Stroke After Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention: Incidence, Pathogenesis, and Outcomes.

Authors:  Mario Gaudino; Dominick J Angiolillo; Antonino Di Franco; Davide Capodanno; Faisal Bakaeen; Michael E Farkouh; Stephen E Fremes; David Holmes; Leonard N Girardi; Sunao Nakamura; Stuart J Head; Seung-Jung Park; Michael Mack; Patrick W Serruys; Marc Ruel; Gregg W Stone; Derrick Y Tam; Michael Vallely; David P Taggart
Journal:  J Am Heart Assoc       Date:  2019-06-27       Impact factor: 5.501

10.  Most deaths in low-risk cardiac surgery could be avoidable.

Authors:  Omar Asdrúbal Vilca Mejia; Gabrielle Barbosa Borgomoni; Eduardo Gomes Lima; Gustavo Pampolha Guerreiro; Luís Roberto Dallan; Pedro de Barros E Silva; Marcelo Arruda Nakazone; Orlando Petrucci Junior; Walter José Gomes; Marco Antonio Praça de Oliveira; Alexandre Sousa; Valquíria Pelisser Campagnucci; Marcos Gradim Tiveron; Alfredo José Rodrigues; Rafael Ângelo Tineli; Roberto Rocha E Silva; Luiz Augusto Ferreira Lisboa; Fabio Biscegli Jatene
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.